Life Science

Zydis technology will be applied to four of the Cambridge company’s products.

The St John’s Innovation Park company will integrate its platform into Veeva CRM Suggestions

PRECIOUS study follows successful launch of IBD prognostic test in UK and Ireland.

Staff and assets at its US-based research models business will transfer over.

Chris Russo's group has shown how the prohibitive costs of cryo-electron microscopy could be slashed.

Work at Cambridge Science Park laboratory will integrate mass spectrometer into Breath Biopsy platform.

Among those attending were Sir David Klenerman and Sir Shankar Balasubramanian, who invented sequencing technology.

Cambridge investors fund St Ives-based Sense Bioscience to the tune of £12.3m

The biopharmaceutical company's Centre for Genomics Research will achieve a fourfold increase in storage capacity.

A fantastic array of talent was celebrated at the ceremony.

Winners will be revealed tonight (October 30) in a ceremony at The Bradfield Centre.

CEO Pascal Soriot hails a strong performance from new drugs and in key markets.

There is no such thing as the male or female brain, according to the latest research

Work with US researchers has shown potential for new therapies or stem cell transplantation into the brains of patients.

‘Ambitious’ and ‘fearless’, he was key to one of the greatest achievements in modern molecular biology.

DECIPHER and Mastermind will help clinicians diagnose disease.

It could help provide much more localised, higher dose.

The second cohort of winners are beginning their five-month programme.

The former MedImmune site leader says company's platform has the ability to address many of the current challenges of cell therapy.

It showed potential benefit of adding drug to standard treatment